93/11 (Pantoprazole sodium delayed-release 20 mg)

Pill imprint 93/11 has been identified as Pantoprazole sodium delayed-release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed-release

Imprint:

93/11

Strength:

20 mg

Color:

Yellow

Size:

8.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Proton pump inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA

National Drug Code (NDC):

00093-0011

Inactive Ingredients:

calcium carbonate
calcium stearate
D&C Yellow No. 10
aluminum oxide
FD&C Yellow No. 6
hypromellose 2910 (15 mPa.s)
ferrosoferric oxide
ferric oxide yellow
lactose monohydrate
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol 4000
propylene glycol
shellac
sodium carbonate
stearic acid
magnesium silicate
titanium dioxide
triethyl citrate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0658	AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.